Effect of a standardized pharyngitis treatment protocol on use of antibiotics in a pediatric emergency department

Archives of Pediatrics and Adolescent Medicine

Volumn 158, Issue 10, 2004, Pages 977-981

  Diaz, Maria Carmen G ^a,b,c   Symons, Nadine ^a,b   Ramundo, Maria L ^a,b   Christopher, Norman C ^a,b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b AKRON CHILDREN'S HOSPITAL   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN V POTASSIUM;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; DATA BASE; DRUG CHOICE; DRUG USE; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD; MICROBIOLOGICAL EXAMINATION; PEDIATRICS; PHARYNGITIS; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; STANDARD; TEACHING HOSPITAL; UNITED STATES;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HUMANS; MALE; PHARYNGITIS; PRACTICE GUIDELINES; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 4744352159     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.158.10.977     Document Type: Review

References (26)

1. Tanz RR, Shulman ST. Diagnosis and treatment of group A streptococcal pharyngitis. Semin Pediatr Infect Dis. 1995;6:69-78.
2. Pichichero ME. Group A beta-hemolytic streptococcal infections. Pediatr Rev. 1998;19:291-293.
3. Breese BB. A simple scorecard for tentative diagnosis of streptococcal pharyngitis. AJDC. 1977;131:514-517.
4. Dajani AS, Bisno AI, Chung KJ, et al. Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation. 1988;78:1082-1086.
5. Denson MR. Viral pharyngitis. Semin Pediatr Infect Dis. 1995;6:62-68.
6. Poses RM, Cebul RD, Collins M, Fager SS. The accuracy of experienced physicians' probability estimates for patients with sore throat: implications for decision making. JAMA. 1985;254:925-929.
7. Ehrlich JE, Demopoulos BP, Daniel KR, Ricarte MC, Glied S. Cost-effectiveness of treatment options for prevention of rheumatic heart disease from group A streptococcal pharyngitis in a pediatric population. Prev Med. 2002;35:250-257.
8. Kaplan EL. The rapid identification of group A beta-hemolytic streptococci in the upper respiratory tract: current status. Pediatr Clin North Am. 1988;35:535-542.
9. Shulman ST. Streptococcal pharyngitis: diagnostic considerations. Pediatr Infect Dis J. 1994;13:567-571.
10. American Academy of Pediatrics. 2003 Red Book: Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, III: American Academy of Pediatrics; 2003:573-584.
11. Gopichand I, Williams GD, Medendorp SV, et al. Randomized, single blinded comparative study of the efficacy of amoxicillin (40 mg/kg/day) versus standard-dose penicillin V in the treatment of group A streptococcal pharyngitis in children. Clin Pediatr (Phila). 1998;37:341-346.
12. Cohen R. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Pediatr Infect Dis J. 2004;23:S129-S134.
13. Schwartz B, Marcy M, Phillips WR, Gerber MA, Dowell SF. Pharyngitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:171-174.
14. Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J. 1994;13:1-7.
15. Powell CV. How to implement changes in clinical practice. Paediatr Respir Rev. 2003;4:340-346.
16. Schulte B, O'Hea EL, Darling P. Putting clinical guidelines into practice. Fam Pract Manag. 2001;8:45-46.
17. Brindis RG, Sennett C. Physician adherence to clinical practice guidelines: does it really matter? Am Heart J. 2003;145:13-15.
18. Attiá MW, Zaoutis T, Klein JD, Meier FA. Performance of a predictive model for streptococcal pharyngitis in children. Arch Pediatr Adolesc Med. 2001;155:687-691.
19. Needham CA, McPherson KA, Webb KH. Streptococcal pharyngitis: impact of a high-sensitivity antigen test on physician outcome. J Clin Microbiol. 1998;36:3468-3473.
20. Schaad UB, Kellerhals P, Altwegg M; the Swiss Pharyngitis Study Group. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. Pediatr Infect Dis J. 2002;21:304-308.
21. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991;10:275-281.
22. Deeter RG, Kalman DL, Rogan MP, Chow SC. Therapy of pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V. Clin Ther. 1992;14:740-754.,
23. Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics. 2004;113:866-882.
24. Thermo BioStar STREP A OIA MAX: an enhanced optical immunoassay for the rapid detection of group A streptococcal antigen from throat swabs [package insert]. Revision 10. Louisville, Colo: Thermo BioStar; 2003.
25. McIssac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291:1587-1595.
26. Tsevat J, Kotagal UR. Management of sore throats in children: a cost-effective analysis. Arch Pediatr Adolesc Med. 1999;153:681-688.